🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Kansas

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Kansas

4 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan Kansas.

Vil nan Kansas

Tèks ofisyèl etid la (Anglè)

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

  • University of Kansas Medical Center (KUMC), Kansas City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06995677

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

  • The University of Kansas - Clinical Research Center, Fairway
  • The University of Kansas Hospital Cambridge North Tower A, Kansas City
  • The University of Kansas Hospital, Kansas City
  • ak 3 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07206225

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • University of Kansas Medical Center, Kansas City
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

Blue Light Cystoscopy With Cysview® Registry

  • University of Kansas Medical Center, Kansas City
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.